Abstract
Phospholipase A2 is the key enzyme for the release of arachidonic acid derived mediators via cycloxygenase or lipoxygenase pathways in inflammation and immunological processes. Activity of microsomal phospholipase A2 in rat lung can be inhibited byin vivo application of the ß-adrenergic drug fenoterol both in control and diseased animals.
Similar content being viewed by others
References
D.P. Wallach andV.J.R. Brown,Studies on the arachidonic acid cascade inhibition of phospholipase A 2 in vitro and in vivo by inhibitors, Biochem. Pharmac.30, 1315 (1981).
R.J. Flower andG.J. Blackwell,Anti-inflammatory steroids induce biosynthesis of a phospholipase inhibitor which prevents prostaglandin generation, Nature, Lond.278, 456 (1979).
M.J. Oyarzun andJ.A. Clements,Control of lung surfactant by ventilation, adrenergic mediators, and prostaglandins in the rabbit, Am. Rev. resp. Dis.117, 879 (1978).
L.G. Dobbs andR.J. Mason,Pulmonary alveolar type II cells isolated from rats. J. clin. Invest.63, 378 (1979).
J.W. Rubin, G.H.A. Clowes Jr., M.F Macnocol andJ.W. Gawin,Impaired pulmonary surfactant synthesis in starvation and severe non-thoracic sepsis, Am. J. Surg.123, 461 (1972).
P. v. Wichert, U. Wiegers, W. Stephan, A. Huck, P. Eckert andK. Riesner,Altered metabolism of phospholipids in the lung of rats with peritonitis, Res. exp. Med.172, 223 (1978).
P. v. Wichert, M. Temmesfeld andW. Meyer,Influence of septic shock upon phosphatidylcholine remodelling mechanism in rat lung, Biochim. biophys. Acta664, 487 (1981).
R.H. Demling, M. Smith, R. Gunther, J.T. Flynn andM.H. Gee,Pulmonary injury and prostaglandin production during endotoxinemia in conscious sheep, Am. J. Physiol.240, H348 (1981).
R.B. Passi andF. Possmayer, Surfactant metabolism in acute pancreatitis. InClinical Importance of Surfactant Defects, p. 136 (Ed.P.V. Wichert). Karger Verlag, Basel, New York 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
v. Wichert, P., Meyer, W. In vivo inhibition of phospholipaseA 2 in rat lung by an β-adrenergic agonist. Agents and Actions 13, 233–234 (1983). https://doi.org/10.1007/BF01967339
Issue Date:
DOI: https://doi.org/10.1007/BF01967339